Literature DB >> 9310113

Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease.

T Matsubara1, Y Umezawa, S Tsuru, T Motohashi, K Yabuta, S Furukawa.   

Abstract

Kawasaki disease (KD) is one of the most important forms of vasculitis, and is characterized by the initiation of a proinflammatory cytokine cascade. To further characterize the immunological profile of KD, we measured the serum levels of transforming growth factor-beta 1 (TGF-beta 1) as a regulatory cytokine. We determined the concentration of TGF-beta 1 in the sera of the patients with KD, anaphylactoid purpura (AP), and scarlet fever, using a sandwich enzyme linked immunosorbent assay. The serum levels of TGF-beta 1 were decreased in patients with KD, but not in patients with AP or scarlet fever during the acute stage. We found an inverse correlation between TGF-beta 1 and soluble tumor necrosis factor (TNF) receptor levels in KD patients during the acute and subacute stage. Decreased levels of TGF-beta 1, in particular to suppress TNF alpha (TNF-alpha) production, is an important part of the regulatory system of increased TNF-alpha production which cause vasculitis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9310113     DOI: 10.3109/03009749709105322

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  6 in total

1.  Transforming growth factor-beta signaling pathway in patients with Kawasaki disease.

Authors:  Chisato Shimizu; Sonia Jain; Sonia Davila; Martin L Hibberd; Kevin O Lin; Delaram Molkara; Jeffrey R Frazer; Shelly Sun; Annette L Baker; Jane W Newburger; Anne H Rowley; Stanford T Shulman; Sonia Davila; David Burgner; Willemijn B Breunis; Taco W Kuijpers; Victoria J Wright; Michael Levin; Hariklia Eleftherohorinou; Lachlan Coin; Stephen J Popper; David A Relman; Wen Fury; Calvin Lin; Scott Mellis; Adriana H Tremoulet; Jane C Burns
Journal:  Circ Cardiovasc Genet       Date:  2010-12-02

2.  Inhibition of transforming growth factor β worsens elastin degradation in a murine model of Kawasaki disease.

Authors:  Cristina M Alvira; Christophe Guignabert; Yu-Mee Kim; Chihhsin Chen; Lingli Wang; Trang T Duong; Rae S M Yeung; Dean Y Li; Marlene Rabinovitch
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 3.  Kawasaki disease.

Authors:  Dong Soo Kim
Journal:  Yonsei Med J       Date:  2006-12-31       Impact factor: 2.759

4.  Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease.

Authors:  Yu Mi Choi; Kye Sik Shim; Kyung Lim Yoon; Mi Young Han; Sung Ho Cha; Su Kang Kim; Joo Ho Jung
Journal:  Korean J Pediatr       Date:  2012-01-31

5.  Interleukin-6, vascular endothelial growth factor and transforming growth factor beta 1 in canine steroid responsive meningitis-arteritis.

Authors:  Arianna Maiolini; Meike Otten; Marion Hewicker-Trautwein; Regina Carlson; Andrea Tipold
Journal:  BMC Vet Res       Date:  2013-02-04       Impact factor: 2.741

Review 6.  Current perspectives on Kawasaki disease.

Authors:  Monesha Gupta-Malhotra; P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.